Yujun Xu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Yujun Xu has a total of 128 co-authors. Here are the top co-authors by number of shared publications:
- Ulrich Mansmann
Institute for Medical Information Processing, Biometry and Epidemiology (IBE), Faculty of Medicine, LMU Munich, Munich, Germany
3 shared publications - Lars Hartwin Lindner
Department of Medicine III, LMU University Hospital, Munich, Germany
2 shared publications - Simon Sirtl
Department of Medicine II, LMU University Hospital, Munich, Germany
2 shared publications Ulrich Mansmann
Ludwig Maximilian University Munich Institute of Medical Data Processing Biometrics and Epidemiology, Germany
2 shared publicationsA. Flörcken
Department of Hematology, Oncology and Tumorimmunology, Charité Universitätsmedizin Berlin, Berlin, Germany
1 shared publication- Alexander Kleger
Institute of Molecular Oncology and Stem Cell Biology Ulm University Hospital Ulm Germany
1 shared publication
Latest Publications
- Open Access
- 31 October 2026
- Published by Elsevier in Pancreatology
Sludge-induced acute pancreatitis is linked to lower cholecystectomy rates than gallstone pancreatitis
- 31 October 2026
- Published by Elsevier in Pancreatology
Open AccessSludge-induced acute pancreatitis is linked to lower cholecystectomy rates than gallstone pancreatitis
- Open Access
- 25 October 2025
- Published by Wiley in United European Gastroenterology Journal
- Vol. 13 (10) , 2075-2089
Common Practice of Percutaneous Drainage in Necrotising Pancreatitis—A Multicentre Retrospective Study (DRACULA)
Background and Aims: Acute necrotising pancreatitis carries high mortality, especially if infected necrosis occurs. While percutaneous drainage may be required when internal drainage is not feasible, reliable guidelines for managing percutaneous drains are lacking. This study aimed to assess the common practice of percutaneous drainage therapy for infected pancreatic necrosis. Methods: This retrospective study among 29 tertiary care centres included all patients hospitalised for necrotising acute pancreatitis from 01/2016 until 12/2022 with at least one percutaneous drain. The length of hospital stay was the primary endpoint, with mortality as the secondary endpoint. Between‐group comparisons were conducted using the ratio of restricted mean survival time (RMST) after adjusting for confounders. Results: 585 patients (67% male) from 29 tertiary care centres in 15 countries in Europe, Canada and Bolivia were included in the analysis. Length of hospitalisation or mortality did not differ between the flushed ( n = 398) and non‐flushed groups (RMST ratio 1.04, p ‐value = 0.42 and RMST ratio 1.05, p ‐value = 0.1 respectively). Mortality was significantly lower in those patients who received a combination of percutaneous and internal drains (dual‐modality drainage, n = 243) as compared to those who received percutaneous drains only (RMST ratio 1.05, p ‐value = 0.01). Flushing with antibiotics as compared to saline was not associated with shorter length of hospital stay or lower mortality (RMST ratio 0.98, p ‐value = 0.78 and 0.97, p ‐value = 0.48 respectively). Conclusions: This study reveals notable differences in therapeutic concepts and flushing management for percutaneous drains. While flushing itself was not associated with a shorter length of hospitalisation or lower in‐hospital mortality, a lower mortality was observed when internal and percutaneous drainage were used in combination. Clinical Trial Registration: The study was prospectively registered in the German Clinical Trials Register (Deutsches Register Klinischer Studien, DRKS) under the registration number DRKS00032231.
- 25 October 2025
- Published by Wiley in United European Gastroenterology Journal
- Vol. 13 (10) , 2075-2089
Open AccessCommon Practice of Percutaneous Drainage in Necrotising Pancreatitis—A Multicentre Retrospective Study (DRACULA)
Background and Aims: Acute necrotising pancreatitis carries high mortality, especially if infected necrosis occurs. While percutaneous drainage may be required when internal drainage is not feasible, reliable guidelines for managing percutaneous drains are lacking. This study aimed to assess the common practice of percutaneous drainage therapy for infected pancreatic necrosis. Methods: This retrospective study among 29 tertiary care centres included all patients hospitalised for necrotising acute pancreatitis from 01/2016 until 12/2022 with at least one percutaneous drain. The length of hospital stay was the primary endpoint, with mortality as the secondary endpoint. Between‐group comparisons were conducted using the ratio of restricted mean survival time (RMST) after adjusting for confounders. Results: 585 patients (67% male) from 29 tertiary care centres in 15 countries in Europe, Canada and Bolivia were included in the analysis. Length of hospitalisation or mortality did not differ between the flushed ( n = 398) and non‐flushed groups (RMST ratio 1.04, p ‐value = 0.42 and RMST ratio 1.05, p ‐value = 0.1 respectively). Mortality was significantly lower in those patients who received a combination of percutaneous and internal drains (dual‐modality drainage, n = 243) as compared to those who received percutaneous drains only (RMST ratio 1.05, p ‐value = 0.01). Flushing with antibiotics as compared to saline was not associated with shorter length of hospital stay or lower mortality (RMST ratio 0.98, p ‐value = 0.78 and 0.97, p ‐value = 0.48 respectively). Conclusions: This study reveals notable differences in therapeutic concepts and flushing management for percutaneous drains. While flushing itself was not associated with a shorter length of hospitalisation or lower in‐hospital mortality, a lower mortality was observed when internal and percutaneous drainage were used in combination. Clinical Trial Registration: The study was prospectively registered in the German Clinical Trials Register (Deutsches Register Klinischer Studien, DRKS) under the registration number DRKS00032231.
- Open Access
- 28 July 2023
- Published by American Society of Hematology in Blood Advances
- Vol. 7 (15) , 4046-4048
Do sophisticated models give the full picture of allogeneic hematopoietic stem cell transplantation effect?
Yujun Xu, Tobias Herold, Ulrich Robert Mansmann; Do sophisticated models give the full picture of allogeneic hematopoietic stem cell transplantation effect?, Bl
- 28 July 2023
- Published by American Society of Hematology in Blood Advances
- Vol. 7 (15) , 4046-4048
Open AccessDo sophisticated models give the full picture of allogeneic hematopoietic stem cell transplantation effect?
Yujun Xu, Tobias Herold, Ulrich Robert Mansmann; Do sophisticated models give the full picture of allogeneic hematopoietic stem cell transplantation effect?, Bl
- Open Access
- 16 April 2022
- Published by Springer Nature in Human Genetics
- Vol. 141 (9) , 1467-1480
Validating the knowledge bank approach for personalized prediction of survival in acute myeloid leukemia: a reproducibility study
Reproducibility is not only essential for the integrity of scientific research but is also a prerequisite for model validation and refinement for the future application of predictive algorithms. However, reproducible research is becoming increasingly challenging, particularly in high-dimensional genomic data analyses with complex statistical or algorithmic techniques. Given that there are no mandatory requirements in most biomedical and statistical journals to provide the original data, analytical source code, or other relevant materials for publication, accessibility to these supplements naturally suggests a greater credibility of the published work. In this study, we performed a reproducibility assessment of the notable paper by Gerstung et al. (Nat Genet 49:332–340, 2017) by rerunning the analysis using their original code and data, which are publicly accessible. Despite an open science setting, it was challenging to reproduce the entire research project; reasons included: incomplete data and documentation, suboptimal code readability, coding errors, limited portability of intensive computing performed on a specific platform, and an R computing environment that could no longer be re-established. We learn that the availability of code and data does not guarantee transparency and reproducibility of a study; paradoxically, the source code is still liable to error and obsolescence, essentially due to methodological and computational complexity, a lack of reproducibility checking at submission, and updates for software and operating environment. The complex code may also hide problematic methodological aspects of the proposed research. Building on the experience gained, we discuss the best programming and software engineering practices that could have been employed to improve reproducibility, and propose practical criteria for the conduct and reporting of reproducibility studies for future researchers.
- 16 April 2022
- Published by Springer Nature in Human Genetics
- Vol. 141 (9) , 1467-1480
Open AccessValidating the knowledge bank approach for personalized prediction of survival in acute myeloid leukemia: a reproducibility study
Reproducibility is not only essential for the integrity of scientific research but is also a prerequisite for model validation and refinement for the future application of predictive algorithms. However, reproducible research is becoming increasingly challenging, particularly in high-dimensional genomic data analyses with complex statistical or algorithmic techniques. Given that there are no mandatory requirements in most biomedical and statistical journals to provide the original data, analytical source code, or other relevant materials for publication, accessibility to these supplements naturally suggests a greater credibility of the published work. In this study, we performed a reproducibility assessment of the notable paper by Gerstung et al. (Nat Genet 49:332–340, 2017) by rerunning the analysis using their original code and data, which are publicly accessible. Despite an open science setting, it was challenging to reproduce the entire research project; reasons included: incomplete data and documentation, suboptimal code readability, coding errors, limited portability of intensive computing performed on a specific platform, and an R computing environment that could no longer be re-established. We learn that the availability of code and data does not guarantee transparency and reproducibility of a study; paradoxically, the source code is still liable to error and obsolescence, essentially due to methodological and computational complexity, a lack of reproducibility checking at submission, and updates for software and operating environment. The complex code may also hide problematic methodological aspects of the proposed research. Building on the experience gained, we discuss the best programming and software engineering practices that could have been employed to improve reproducibility, and propose practical criteria for the conduct and reporting of reproducibility studies for future researchers.
- Open Access
- 27 September 2021
- Published by Springer Nature in Research Square
Validating the Knowledge Bank Approach for Personalized Prediction of Survival in Acute Myeloid Leukemia: a Reproducibility Study
Reproducibility is not only essential for the integrity of scientific research, but is also a prerequisite of model validation and refinement for future application of (predictive) algorithms. However, reproducible research is becoming increasingly challenging, particularly in high-dimensional genomic data analyses with complex statistical or algorithmic techniques. Given that there are no mandatory requirements in most biomedical and statistical journals to provide the original data, analytical source code, or other relevant materials for publication, accessibility to these supplements naturally suggests a greater credibility of published work. In this study, we performed a reproducibility assessment of the notable paper by Gerstung et al. published in Nature Genetics (2017) by rerunning the analysis using their original code and data, which are publicly accessible. Despite a perfect open science setting, it was challenging to reproduce the entire research project; reasons included coding errors, suboptimal code legibility, incomplete documentation, intensive computations, and an R computing environment that could no longer be re-established. We learn that availability of code and data does not guarantee transparency and reproducibility of a study; in contrast, the source code is still liable to error and obsolescence, essentially due to methodological complexity, lack of editorial reproducibility checking at submission, and updates of software and operating environment. Building on the experience gained, we propose practical criteria for the conduct and reporting of reproducibility studies for future researchers.
- 27 September 2021
- Published by Springer Nature in Research Square
Open AccessValidating the Knowledge Bank Approach for Personalized Prediction of Survival in Acute Myeloid Leukemia: a Reproducibility Study
Reproducibility is not only essential for the integrity of scientific research, but is also a prerequisite of model validation and refinement for future application of (predictive) algorithms. However, reproducible research is becoming increasingly challenging, particularly in high-dimensional genomic data analyses with complex statistical or algorithmic techniques. Given that there are no mandatory requirements in most biomedical and statistical journals to provide the original data, analytical source code, or other relevant materials for publication, accessibility to these supplements naturally suggests a greater credibility of published work. In this study, we performed a reproducibility assessment of the notable paper by Gerstung et al. published in Nature Genetics (2017) by rerunning the analysis using their original code and data, which are publicly accessible. Despite a perfect open science setting, it was challenging to reproduce the entire research project; reasons included coding errors, suboptimal code legibility, incomplete documentation, intensive computations, and an R computing environment that could no longer be re-established. We learn that availability of code and data does not guarantee transparency and reproducibility of a study; in contrast, the source code is still liable to error and obsolescence, essentially due to methodological complexity, lack of editorial reproducibility checking at submission, and updates of software and operating environment. Building on the experience gained, we propose practical criteria for the conduct and reporting of reproducibility studies for future researchers.
- Open Access
- 1 January 2021
- Published by Ivyspring International Publisher in International Journal of Medical Sciences
- Vol. 18 (14) , 3125-3139
Ferumoxytol-β-glucan Inhibits Melanoma Growth via Interacting with Dectin-1 to Polarize Macrophages into M1 Phenotype
Background: Regulating the polarization of macrophages to antitumor M1 macrophages is a promising strategy for overcoming the immunosuppression of the tumor microenvironment for cancer therapy. Ferumoxytol (FMT) can not only serve as a drug deliver agent but also exerts anti-tumor activity. β-glucan has immuno-modulating properties to prevent tumor growth. Thus, a nanocomposite of FMT surface-coated with β-glucan (FMT-β-glucan) was prepared to explore its effect on tumor suppression.
- 1 January 2021
- Published by Ivyspring International Publisher in International Journal of Medical Sciences
- Vol. 18 (14) , 3125-3139
Open AccessFerumoxytol-β-glucan Inhibits Melanoma Growth via Interacting with Dectin-1 to Polarize Macrophages into M1 Phenotype
Background: Regulating the polarization of macrophages to antitumor M1 macrophages is a promising strategy for overcoming the immunosuppression of the tumor microenvironment for cancer therapy. Ferumoxytol (FMT) can not only serve as a drug deliver agent but also exerts anti-tumor activity. β-glucan has immuno-modulating properties to prevent tumor growth. Thus, a nanocomposite of FMT surface-coated with β-glucan (FMT-β-glucan) was prepared to explore its effect on tumor suppression.